Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$81.1K Buy
686
+481
+235% +$55.5K ﹤0.01% 1201
2026
Q1
$24.5K Buy
205
+1
+0.5% +$131 ﹤0.01% 1592
2025
Q4
$27.8K Sell
204
-2
-1% -$288 ﹤0.01% 1556
2025
Q3
$30.4K Buy
206
+45
+28% +$6.24K ﹤0.01% 1518
2025
Q2
$20.8K Sell
161
-22
-12% -$2.66K ﹤0.01% 1599
2025
Q1
$21.9K Buy
183
+67
+58% +$8.3K ﹤0.01% 1495
2024
Q4
$13.5K Sell
116
-288
-71% -$36.4K ﹤0.01% 1668
2024
Q3
$54.6K Sell
404
-1,094
-73% -$146K ﹤0.01% 1148
2024
Q2
$203K Buy
1,498
+1,322
+751% +$180K 0.02% 368
2024
Q1
$22.7K Buy
+176
New +$21.3K ﹤0.01% 1419
2022
Q4
$64.1K Buy
+580
New +$60.8K ﹤0.01% 899
2022
Q3
Sell
-710
Closed -$56K 2147
2022
Q2
$56K Buy
+710
New +$58.6K ﹤0.01% 904
2022
Q1
Sell
-4,008
Closed -$481K 2146
2021
Q4
$481K Buy
+4,008
New +$497K 0.03% 376

Other funds holding XYL

CoreCap Advisors's XYL Position: Q2 2026 in Review

CoreCap Advisors increased its Xylem (XYL) stake by 235% in Q2 2026, buying an estimated $55.5K and bringing the position to 686 shares worth $81.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1201.

CoreCap Advisors first reported a position in XYL in Q4 2021 and has held it in 13 quarters since. The position peaked at $481K in Q4 2021. 1,098 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • CoreCap Advisors held 686 shares of Xylem worth $81.1K as of Q2 2026.
  • CoreCap Advisors bought 481 Xylem shares in Q2 2026, an estimated $55.5K.
  • Xylem made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #1201 holding.
  • CoreCap Advisors first reported a position in Xylem in Q4 2021 and has held it in 13 quarters since.
  • CoreCap Advisors's Xylem position peaked at $481K in Q4 2021.
  • 1,098 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.